Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Peter Sandner, Niels Svenstrup, Hanna Tinel, Helmut Haning & Erwin Bischoff. (2008) Phosphodiesterase 5 inhibitors and erectile dysfunction. Expert Opinion on Therapeutic Patents 18:1, pages 21-33.
Read now
Read now
Articles from other publishers (9)
Ahmed K. ElHady, Shou-Ping Shih, Yu-Cheng Chen, Yi-Chang Liu, Nermin S. Ahmed, Adam B. Keeton, Gary A. Piazza, Matthias Engel, Ashraf H. Abadi & Mohammad Abdel-Halim. (2020) Extending the use of tadalafil scaffold: Development of novel selective phosphodiesterase 5 inhibitors and histone deacetylase inhibitors. Bioorganic Chemistry 98, pages 103742.
Crossref
Crossref
Juan Alberto Sirvent & Ulrich Lücking. (2017) Novel Pieces for the Emerging Picture of Sulfoximines in Drug Discovery: Synthesis and Evaluation of Sulfoximine Analogues of Marketed Drugs and Advanced Clinical Candidates. ChemMedChem 12:7, pages 487-501.
Crossref
Crossref
Nermin S. Ahmed, Amal H. Ali, Shreen M. El-Nashar, Bernard D. Gary, Alexandra M. Fajardo, Heather N. Tinsley, Gary A. Piazza, Matthias Negri & Ashraf H. Abadi. (2012) Exploring the PDE5 H-pocket by ensemble docking and structure-based design and synthesis of novel β-carboline derivatives. European Journal of Medicinal Chemistry 57, pages 329-343.
Crossref
Crossref
Nagula Shankaraiah & Leonardo Silva Santos. (2009) Enantioselective total synthesis of pyrroloquinolone as a potent PDE5 inhibitor. Tetrahedron Letters 50:5, pages 520-523.
Crossref
Crossref
D.P. Rotella. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
919
957
.
Hyun-Il Shin, Juyoung Lee & Dae-Kee Kim. (2006) Synthesis of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazin-1-ylsulfonyl]-2-n-propoxyphenyl}-7-n-propyl-3,5-dihydro-4H-pyrrolo[3,2-d]-[2-14C]pyrimidin-4-one·2 HCl (14C-SK3530·2 HCl). Journal of Labelled Compounds and Radiopharmaceuticals 49:13, pages 1141-1149.
Crossref
Crossref
Y Qiu, S Bhattacharjee, P Kraft, T Mathew John, D Haynes-Johnson, W Jiang, Z Sui & S Lundeen. (2006) JNJ-10280205 and JNJ-10287069: novel PDE5 inhibitors as clinical candidates for erectile dysfunction. International Journal of Impotence Research 18:5, pages 477-483.
Crossref
Crossref
Guangxin Xia, Jianfeng Li, Aiming Peng, Shunan Lai, Shujun Zhang, Jingshan Shen, Zhonghua Liu, Xinjian Chen & Ruyun Ji. (2005) Synthesis and phosphodiesterase 5 inhibitory activity of novel pyrido[1,2-e]purin-4(3H)-one derivatives. Bioorganic & Medicinal Chemistry Letters 15:11, pages 2790-2794.
Crossref
Crossref
Weiqin Jiang, Vernon C Alford, Yuhong Qiu, Sheela Bhattacharjee, T.Matthew John, Donna Haynes-Johnson, Patricia J Kraft, Scott G Lundeen & Zhihua Sui. (2004) Synthesis and SAR of tetracyclic pyrroloquinolones as phosphodiesterase 5 inhibitors. Bioorganic & Medicinal Chemistry 12:6, pages 1505-1515.
Crossref
Crossref